This intervention addressed the effects of an unhealthy diet that may promote the growth of LPS-producing bacteria, leading to LPS translocation caused by intestinal barrier compromise and subsequent metabolic disorders, insulin resistance, systemic inflammation, and immune responses [24]. The gene discussed is INS; the disease is metabolic disease.